Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Feb 8, 2019. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6145-25
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)
Initial Posting
Feb 8, 2019

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.